Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voglimust MF 2mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Prophex Health Care Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Voglimust MF 2mg/500mg/0.3mg Tablet

Diabetol-MF 2mg/500mg/0.3mg tablets are classified as antidiabetic medications. This combination drug treats type 2 diabetes in adults by regulating blood glucose. Diabetol-MF should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney damage, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Knowing the signs and having readily available glucose (e.g., sugary snacks or juice) is vital for management. Alcohol consumption should be minimized due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may also occur. Diabetol-MF is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should consult their doctor before use. Regular blood glucose monitoring is necessary, and your physician may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Voglimust MF 2mg/500mg/0.3mg Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Voglimust MF 2mg/500mg/0.3mg Tablet

Managing Type 2 diabetes

Major Benefits of Voglimust MF 2mg/500mg/0.3mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the Voglimust MF 2mg/500mg/0.3mg tablet whole; do not chew, crush, or fracture it. Consumption should be on an empty stomach.

Common Side effects of Voglimust MF 2mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Voglimust MF 2mg/500mg/0.3mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Voglimust MF 2mg/500mg/0.3mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken on an empty stomach.

How Voglimust MF 2mg/500mg/0.3mg Tablet works:

Voglimust MF tablets (2mg/500mg/0.3mg) contain a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Voglimust MF 2mg/500mg/0.3mg Tablet with alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Voglimust MF 2mg/500mg/0.3mg Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Voglimust MF 2mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

The use of Voglimust MF 2mg/500mg/0.3mg tablets is likely unsafe for individuals with kidney impairment and should be avoided. Medical advice is recommended. Furthermore, this medication is contraindicated in patients with severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Voglimust MF 2mg/500mg/0.3mg tablets cautiously, as dose modification may be necessary. Individuals with mild to moderate liver disease should begin with a reduced dosage; however, its use is contraindicated in those with severe liver dysfunction. Medical advice is recommended.

What if you forget to take Voglimust MF 2mg/500mg/0.3mg Tablet :

Should you forget a Voglimust MF 2mg/500mg/0.3mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voglimust MF 2mg/500mg/0.3mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Voglimust MF 2mg/500mg/0.3mg Tablet

Voglimust MF 2mg/500mg/0.3mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 diabetes.
Voglimust MF 2mg/500mg/0.3mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste, flatulence, abdominal pain, headache, rash, and respiratory infections.
Voglimust MF 2mg/500mg/0.3mg Tablet is contraindicated in patients allergic to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis).
Consuming alcohol with Voglimust MF 2mg/500mg/0.3mg Tablet is unsafe. This combination can worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Voglimust MF 2mg/500mg/0.3mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source like glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Voglimust MF 2mg/500mg/0....
111
MRP 136
18% off